The global Structural Heart Occlusion Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Structural Heart Occlusion Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Structural heart occlusion devices are specialized medical tools designed to treat various structural heart diseases by closing abnormal openings or defects in the heart. These devices enable minimally invasive procedures, which offer significant benefits over traditional open-heart surgeries.

The North American market for Structural Heart Occlusion Devices is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Structural Heart Occlusion Devices is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Structural Heart Occlusion Devices include Abbott, Medtronic, Boston Scientific, MicroPort, Shenzhen Salubris Pharmaceuticals, LifeTech, Lepu Scientech Medical, Beijing Balance Medical, Bluesail Medical, Shanghai HeartCare Medical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Structural Heart Occlusion Devices market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Structural Heart Occlusion Devices. The Structural Heart Occlusion Devices market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Structural Heart Occlusion Devices market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Structural Heart Occlusion Devices manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Structural Heart Occlusion Devices Market Report

Report Metric	Details
Report Name	Structural Heart Occlusion Devices Market
Segment by Type	Patent Ductus Arteriosis (PDA) Occluder Atrial Septal Defects (ASD) Occluder Ventricular Septal Defects (VSD) Occluder Left Atrial Appendage （LAA） Occluder Patent Foramen Ovale (PFO) Occluder
by Application	Congenital Heart Disease Cardioembolic Stroke
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abbott, Medtronic, Boston Scientific, MicroPort, Shenzhen Salubris Pharmaceuticals, LifeTech, Lepu Scientech Medical, Beijing Balance Medical, Bluesail Medical, Shanghai HeartCare Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Structural Heart Occlusion Devices manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Structural Heart Occlusion Devices sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Structural Heart Occlusion Devices Market report?

Ans: The main players in the Structural Heart Occlusion Devices Market are Abbott, Medtronic, Boston Scientific, MicroPort, Shenzhen Salubris Pharmaceuticals, LifeTech, Lepu Scientech Medical, Beijing Balance Medical, Bluesail Medical, Shanghai HeartCare Medical

What are the Application segmentation covered in the Structural Heart Occlusion Devices Market report?

Ans: The Applications covered in the Structural Heart Occlusion Devices Market report are Congenital Heart Disease, Cardioembolic Stroke

What are the Type segmentation covered in the Structural Heart Occlusion Devices Market report?

Ans: The Types covered in the Structural Heart Occlusion Devices Market report are Patent Ductus Arteriosis (PDA) Occluder, Atrial Septal Defects (ASD) Occluder, Ventricular Septal Defects (VSD) Occluder, Left Atrial Appendage （LAA） Occluder, Patent Foramen Ovale (PFO) Occluder

1 Structural Heart Occlusion Devices Market Overview

1.1 Product Definition

1.2 Structural Heart Occlusion Devices by Type

1.2.1 Global Structural Heart Occlusion Devices Market Value by Type: 2025 vs 2032

1.2.2 Patent Ductus Arteriosis (PDA) Occluder

1.2.3 Atrial Septal Defects (ASD) Occluder

1.2.4 Ventricular Septal Defects (VSD) Occluder

1.2.5 Left Atrial Appendage （LAA） Occluder

1.2.6 Patent Foramen Ovale (PFO) Occluder

1.3 Structural Heart Occlusion Devices by Application

1.3.1 Global Structural Heart Occlusion Devices Market Value by Application: 2025 vs 2032

1.3.2 Congenital Heart Disease

1.3.3 Cardioembolic Stroke

1.4 Global Structural Heart Occlusion Devices Market Size Estimates and Forecasts

1.4.1 Global Structural Heart Occlusion Devices Revenue 2021–2032

1.4.2 Global Structural Heart Occlusion Devices Sales 2021–2032

1.4.3 Global Structural Heart Occlusion Devices Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Structural Heart Occlusion Devices Market Competition by Manufacturers

2.1 Global Structural Heart Occlusion Devices Sales Market Share by Manufacturers (2021–2026)

2.2 Global Structural Heart Occlusion Devices Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Structural Heart Occlusion Devices Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Structural Heart Occlusion Devices, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Structural Heart Occlusion Devices, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Structural Heart Occlusion Devices, Product Types and Applications

2.7 Global Key Manufacturers of Structural Heart Occlusion Devices, Date of Entry into the Industry

2.8 Global Structural Heart Occlusion Devices Market Competitive Situation and Trends

2.8.1 Global Structural Heart Occlusion Devices Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Structural Heart Occlusion Devices Players Market Share by Revenue

2.8.3 Global Structural Heart Occlusion Devices Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Structural Heart Occlusion Devices Market Scenario by Region

3.1 Global Structural Heart Occlusion Devices Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Structural Heart Occlusion Devices Sales by Region: 2021–2032

3.2.1 Global Structural Heart Occlusion Devices Sales by Region: 2021–2026

3.2.2 Global Structural Heart Occlusion Devices Sales by Region: 2027–2032

3.3 Global Structural Heart Occlusion Devices Revenue by Region: 2021–2032

3.3.1 Global Structural Heart Occlusion Devices Revenue by Region: 2021–2026

3.3.2 Global Structural Heart Occlusion Devices Revenue by Region: 2027–2032

3.4 North America Structural Heart Occlusion Devices Market Facts & Figures by Country

3.4.1 North America Structural Heart Occlusion Devices Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Structural Heart Occlusion Devices Sales by Country (2021–2032)

3.4.3 North America Structural Heart Occlusion Devices Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Structural Heart Occlusion Devices Market Facts & Figures by Country

3.5.1 Europe Structural Heart Occlusion Devices Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Structural Heart Occlusion Devices Sales by Country (2021–2032)

3.5.3 Europe Structural Heart Occlusion Devices Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Structural Heart Occlusion Devices Market Facts & Figures by Region

3.6.1 Asia Pacific Structural Heart Occlusion Devices Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Structural Heart Occlusion Devices Sales by Region (2021–2032)

3.6.3 Asia Pacific Structural Heart Occlusion Devices Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Structural Heart Occlusion Devices Market Facts & Figures by Country

3.7.1 Latin America Structural Heart Occlusion Devices Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Structural Heart Occlusion Devices Sales by Country (2021–2032)

3.7.3 Latin America Structural Heart Occlusion Devices Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Structural Heart Occlusion Devices Market Facts & Figures by Country

3.8.1 Middle East and Africa Structural Heart Occlusion Devices Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Structural Heart Occlusion Devices Sales by Country (2021–2032)

3.8.3 Middle East and Africa Structural Heart Occlusion Devices Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Structural Heart Occlusion Devices Sales by Type (2021–2032)

4.1.1 Global Structural Heart Occlusion Devices Sales by Type (2021–2026)

4.1.2 Global Structural Heart Occlusion Devices Sales by Type (2027–2032)

4.1.3 Global Structural Heart Occlusion Devices Sales Market Share by Type (2021–2032)

4.2 Global Structural Heart Occlusion Devices Revenue by Type (2021–2032)

4.2.1 Global Structural Heart Occlusion Devices Revenue by Type (2021–2026)

4.2.2 Global Structural Heart Occlusion Devices Revenue by Type (2027–2032)

4.2.3 Global Structural Heart Occlusion Devices Revenue Market Share by Type (2021–2032)

4.3 Global Structural Heart Occlusion Devices Price by Type (2021–2032)

5 Segment by Application

5.1 Global Structural Heart Occlusion Devices Sales by Application (2021–2032)

5.1.1 Global Structural Heart Occlusion Devices Sales by Application (2021–2026)

5.1.2 Global Structural Heart Occlusion Devices Sales by Application (2027–2032)

5.1.3 Global Structural Heart Occlusion Devices Sales Market Share by Application (2021–2032)

5.2 Global Structural Heart Occlusion Devices Revenue by Application (2021–2032)

5.2.1 Global Structural Heart Occlusion Devices Revenue by Application (2021–2026)

5.2.2 Global Structural Heart Occlusion Devices Revenue by Application (2027–2032)

5.2.3 Global Structural Heart Occlusion Devices Revenue Market Share by Application (2021–2032)

5.3 Global Structural Heart Occlusion Devices Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Abbott

6.1.1 Abbott Company Information

6.1.2 Abbott Description and Business Overview

6.1.3 Abbott Structural Heart Occlusion Devices Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Abbott Structural Heart Occlusion Devices Product Portfolio

6.1.5 Abbott Recent Developments/Updates

6.2 Medtronic

6.2.1 Medtronic Company Information

6.2.2 Medtronic Description and Business Overview

6.2.3 Medtronic Structural Heart Occlusion Devices Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Medtronic Structural Heart Occlusion Devices Product Portfolio

6.2.5 Medtronic Recent Developments/Updates

6.3 Boston Scientific

6.3.1 Boston Scientific Company Information

6.3.2 Boston Scientific Description and Business Overview

6.3.3 Boston Scientific Structural Heart Occlusion Devices Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Boston Scientific Structural Heart Occlusion Devices Product Portfolio

6.3.5 Boston Scientific Recent Developments/Updates

6.4 MicroPort

6.4.1 MicroPort Company Information

6.4.2 MicroPort Description and Business Overview

6.4.3 MicroPort Structural Heart Occlusion Devices Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 MicroPort Structural Heart Occlusion Devices Product Portfolio

6.4.5 MicroPort Recent Developments/Updates

6.5 Shenzhen Salubris Pharmaceuticals

6.5.1 Shenzhen Salubris Pharmaceuticals Company Information

6.5.2 Shenzhen Salubris Pharmaceuticals Description and Business Overview

6.5.3 Shenzhen Salubris Pharmaceuticals Structural Heart Occlusion Devices Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Shenzhen Salubris Pharmaceuticals Structural Heart Occlusion Devices Product Portfolio

6.5.5 Shenzhen Salubris Pharmaceuticals Recent Developments/Updates

6.6 LifeTech

6.6.1 LifeTech Company Information

6.6.2 LifeTech Description and Business Overview

6.6.3 LifeTech Structural Heart Occlusion Devices Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 LifeTech Structural Heart Occlusion Devices Product Portfolio

6.6.5 LifeTech Recent Developments/Updates

6.7 Lepu Scientech Medical

6.7.1 Lepu Scientech Medical Company Information

6.7.2 Lepu Scientech Medical Description and Business Overview

6.7.3 Lepu Scientech Medical Structural Heart Occlusion Devices Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Lepu Scientech Medical Structural Heart Occlusion Devices Product Portfolio

6.7.5 Lepu Scientech Medical Recent Developments/Updates

6.8 Beijing Balance Medical

6.8.1 Beijing Balance Medical Company Information

6.8.2 Beijing Balance Medical Description and Business Overview

6.8.3 Beijing Balance Medical Structural Heart Occlusion Devices Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Beijing Balance Medical Structural Heart Occlusion Devices Product Portfolio

6.8.5 Beijing Balance Medical Recent Developments/Updates

6.9 Bluesail Medical

6.9.1 Bluesail Medical Company Information

6.9.2 Bluesail Medical Description and Business Overview

6.9.3 Bluesail Medical Structural Heart Occlusion Devices Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Bluesail Medical Structural Heart Occlusion Devices Product Portfolio

6.9.5 Bluesail Medical Recent Developments/Updates

6.10 Shanghai HeartCare Medical

6.10.1 Shanghai HeartCare Medical Company Information

6.10.2 Shanghai HeartCare Medical Description and Business Overview

6.10.3 Shanghai HeartCare Medical Structural Heart Occlusion Devices Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Shanghai HeartCare Medical Structural Heart Occlusion Devices Product Portfolio

6.10.5 Shanghai HeartCare Medical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Structural Heart Occlusion Devices Industry Chain Analysis

7.2 Structural Heart Occlusion Devices Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Structural Heart Occlusion Devices Production Mode & Process Analysis

7.4 Structural Heart Occlusion Devices Sales and Marketing

7.4.1 Structural Heart Occlusion Devices Sales Channels

7.4.2 Structural Heart Occlusion Devices Distributors

7.5 Structural Heart Occlusion Devices Customer Analysis

8 Structural Heart Occlusion Devices Market Dynamics

8.1 Structural Heart Occlusion Devices Industry Trends

8.2 Structural Heart Occlusion Devices Market Drivers

8.3 Structural Heart Occlusion Devices Market Challenges

8.4 Structural Heart Occlusion Devices Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Shenzhen Salubris Pharmaceuticals

LifeTech

LEPU SCIENTECH MEDICAL

Beijing Balance Medical

Bluesail Medical

Shanghai HeartCare Medical

List of Tables

Table 1. Global Structural Heart Occlusion Devices Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Structural Heart Occlusion Devices Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Structural Heart Occlusion Devices Market Competitive Situation by Manufacturers in 2025

Table 4. Global Structural Heart Occlusion Devices Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global Structural Heart Occlusion Devices Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Structural Heart Occlusion Devices Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Structural Heart Occlusion Devices Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Structural Heart Occlusion Devices Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Structural Heart Occlusion Devices, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Structural Heart Occlusion Devices, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Structural Heart Occlusion Devices, Product Types and Applications

Table 12. Global Key Manufacturers of Structural Heart Occlusion Devices, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Structural Heart Occlusion Devices Companies by Tier (Tier 1, Tier 2, Tier 3), based on Structural Heart Occlusion Devices Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Structural Heart Occlusion Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Structural Heart Occlusion Devices Sales by Region (K Units), 2021–2026

Table 18. Global Structural Heart Occlusion Devices Sales Market Share by Region (2021–2026)

Table 19. Global Structural Heart Occlusion Devices Sales by Region (K Units), 2027–2032

Table 20. Global Structural Heart Occlusion Devices Sales Market Share by Region (2027–2032)

Table 21. Global Structural Heart Occlusion Devices Revenue by Region (US$ Million), 2021–2026

Table 22. Global Structural Heart Occlusion Devices Revenue Market Share by Region (2021–2026)

Table 23. Global Structural Heart Occlusion Devices Revenue by Region (US$ Million), 2027–2032

Table 24. Global Structural Heart Occlusion Devices Revenue Market Share by Region (2027–2032)

Table 25. North America Structural Heart Occlusion Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Structural Heart Occlusion Devices Sales by Country (K Units), 2021–2026

Table 27. North America Structural Heart Occlusion Devices Sales by Country (K Units), 2027–2032

Table 28. North America Structural Heart Occlusion Devices Revenue by Country (US$ Million), 2021–2026

Table 29. North America Structural Heart Occlusion Devices Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Structural Heart Occlusion Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Structural Heart Occlusion Devices Sales by Country (K Units), 2021–2026

Table 32. Europe Structural Heart Occlusion Devices Sales by Country (K Units), 2027–2032

Table 33. Europe Structural Heart Occlusion Devices Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Structural Heart Occlusion Devices Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Structural Heart Occlusion Devices Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Structural Heart Occlusion Devices Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific Structural Heart Occlusion Devices Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific Structural Heart Occlusion Devices Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Structural Heart Occlusion Devices Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Structural Heart Occlusion Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Structural Heart Occlusion Devices Sales by Country (K Units), 2021–2026

Table 42. Latin America Structural Heart Occlusion Devices Sales by Country (K Units), 2027–2032

Table 43. Latin America Structural Heart Occlusion Devices Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Structural Heart Occlusion Devices Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Structural Heart Occlusion Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Structural Heart Occlusion Devices Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa Structural Heart Occlusion Devices Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa Structural Heart Occlusion Devices Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Structural Heart Occlusion Devices Revenue by Country (US$ Million), 2027–2032

Table 50. Global Structural Heart Occlusion Devices Sales (K Units) by Type (2021–2026)

Table 51. Global Structural Heart Occlusion Devices Sales (K Units) by Type (2027–2032)

Table 52. Global Structural Heart Occlusion Devices Sales Market Share by Type (2021–2026)

Table 53. Global Structural Heart Occlusion Devices Sales Market Share by Type (2027–2032)

Table 54. Global Structural Heart Occlusion Devices Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Structural Heart Occlusion Devices Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Structural Heart Occlusion Devices Revenue Market Share by Type (2021–2026)

Table 57. Global Structural Heart Occlusion Devices Revenue Market Share by Type (2027–2032)

Table 58. Global Structural Heart Occlusion Devices Price (US$/Unit) by Type (2021–2026)

Table 59. Global Structural Heart Occlusion Devices Price (US$/Unit) by Type (2027–2032)

Table 60. Global Structural Heart Occlusion Devices Sales (K Units) by Application (2021–2026)

Table 61. Global Structural Heart Occlusion Devices Sales (K Units) by Application (2027–2032)

Table 62. Global Structural Heart Occlusion Devices Sales Market Share by Application (2021–2026)

Table 63. Global Structural Heart Occlusion Devices Sales Market Share by Application (2027–2032)

Table 64. Global Structural Heart Occlusion Devices Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Structural Heart Occlusion Devices Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Structural Heart Occlusion Devices Revenue Market Share by Application (2021–2026)

Table 67. Global Structural Heart Occlusion Devices Revenue Market Share by Application (2027–2032)

Table 68. Global Structural Heart Occlusion Devices Price (US$/Unit) by Application (2021–2026)

Table 69. Global Structural Heart Occlusion Devices Price (US$/Unit) by Application (2027–2032)

Table 70. Abbott Company Information

Table 71. Abbott Description and Business Overview

Table 72. Abbott Structural Heart Occlusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. Abbott Structural Heart Occlusion Devices Product

Table 74. Abbott Recent Developments/Updates

Table 75. Medtronic Company Information

Table 76. Medtronic Description and Business Overview

Table 77. Medtronic Structural Heart Occlusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Medtronic Structural Heart Occlusion Devices Product

Table 79. Medtronic Recent Developments/Updates

Table 80. Boston Scientific Company Information

Table 81. Boston Scientific Description and Business Overview

Table 82. Boston Scientific Structural Heart Occlusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. Boston Scientific Structural Heart Occlusion Devices Product

Table 84. Boston Scientific Recent Developments/Updates

Table 85. MicroPort Company Information

Table 86. MicroPort Description and Business Overview

Table 87. MicroPort Structural Heart Occlusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. MicroPort Structural Heart Occlusion Devices Product

Table 89. MicroPort Recent Developments/Updates

Table 90. Shenzhen Salubris Pharmaceuticals Company Information

Table 91. Shenzhen Salubris Pharmaceuticals Description and Business Overview

Table 92. Shenzhen Salubris Pharmaceuticals Structural Heart Occlusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. Shenzhen Salubris Pharmaceuticals Structural Heart Occlusion Devices Product

Table 94. Shenzhen Salubris Pharmaceuticals Recent Developments/Updates

Table 95. LifeTech Company Information

Table 96. LifeTech Description and Business Overview

Table 97. LifeTech Structural Heart Occlusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. LifeTech Structural Heart Occlusion Devices Product

Table 99. LifeTech Recent Developments/Updates

Table 100. Lepu Scientech Medical Company Information

Table 101. Lepu Scientech Medical Description and Business Overview

Table 102. Lepu Scientech Medical Structural Heart Occlusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 103. Lepu Scientech Medical Structural Heart Occlusion Devices Product

Table 104. Lepu Scientech Medical Recent Developments/Updates

Table 105. Beijing Balance Medical Company Information

Table 106. Beijing Balance Medical Description and Business Overview

Table 107. Beijing Balance Medical Structural Heart Occlusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 108. Beijing Balance Medical Structural Heart Occlusion Devices Product

Table 109. Beijing Balance Medical Recent Developments/Updates

Table 110. Bluesail Medical Company Information

Table 111. Bluesail Medical Description and Business Overview

Table 112. Bluesail Medical Structural Heart Occlusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 113. Bluesail Medical Structural Heart Occlusion Devices Product

Table 114. Bluesail Medical Recent Developments/Updates

Table 115. Shanghai HeartCare Medical Company Information

Table 116. Shanghai HeartCare Medical Description and Business Overview

Table 117. Shanghai HeartCare Medical Structural Heart Occlusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 118. Shanghai HeartCare Medical Structural Heart Occlusion Devices Product

Table 119. Shanghai HeartCare Medical Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Structural Heart Occlusion Devices Distributors List

Table 123. Structural Heart Occlusion Devices Customers List

Table 124. Structural Heart Occlusion Devices Market Trends

Table 125. Structural Heart Occlusion Devices Market Drivers

Table 126. Structural Heart Occlusion Devices Market Challenges

Table 127. Structural Heart Occlusion Devices Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Structural Heart Occlusion Devices

Figure 2. Global Structural Heart Occlusion Devices Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Structural Heart Occlusion Devices Market Share by Type: 2025 & 2032

Figure 4. Patent Ductus Arteriosis (PDA) Occluder Product Picture

Figure 5. Atrial Septal Defects (ASD) Occluder Product Picture

Figure 6. Ventricular Septal Defects (VSD) Occluder Product Picture

Figure 7. Left Atrial Appendage （LAA） Occluder Product Picture

Figure 8. Patent Foramen Ovale (PFO) Occluder Product Picture

Figure 9. Global Structural Heart Occlusion Devices Market Value by Application (US$ Million), 2021–2032

Figure 10. Global Structural Heart Occlusion Devices Market Share by Application: 2025 & 2032

Figure 11. Congenital Heart Disease

Figure 12. Cardioembolic Stroke

Figure 13. Global Structural Heart Occlusion Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Structural Heart Occlusion Devices Market Size (US$ Million), 2021–2032

Figure 15. Global Structural Heart Occlusion Devices Sales (K Units), 2021–2032

Figure 16. Global Structural Heart Occlusion Devices Average Price (US$/Unit), 2021–2032

Figure 17. Structural Heart Occlusion Devices Report Years Considered

Figure 18. Structural Heart Occlusion Devices Sales Share by Manufacturers in 2025

Figure 19. Global Structural Heart Occlusion Devices Revenue Share by Manufacturers in 2025

Figure 20. Top 5 and Top 10 Global Structural Heart Occlusion Devices Players: Market Share by Revenue in Structural Heart Occlusion Devices in 2025

Figure 21. Structural Heart Occlusion Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 22. Global Structural Heart Occlusion Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 23. North America Structural Heart Occlusion Devices Sales Market Share by Country (2021–2032)

Figure 24. North America Structural Heart Occlusion Devices Revenue Market Share by Country (2021–2032)

Figure 25. U.S. Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 26. Canada Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 27. Europe Structural Heart Occlusion Devices Sales Market Share by Country (2021–2032)

Figure 28. Europe Structural Heart Occlusion Devices Revenue Market Share by Country (2021–2032)

Figure 29. Germany Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. France Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. U.K. Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Italy Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Russia Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Asia Pacific Structural Heart Occlusion Devices Sales Market Share by Region (2021–2032)

Figure 35. Asia Pacific Structural Heart Occlusion Devices Revenue Market Share by Region (2021–2032)

Figure 36. China Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Japan Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. South Korea Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. India Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Australia Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Taiwan Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Indonesia Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Thailand Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Malaysia Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Philippines Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Latin America Structural Heart Occlusion Devices Sales Market Share by Country (2021–2032)

Figure 47. Latin America Structural Heart Occlusion Devices Revenue Market Share by Country (2021–2032)

Figure 48. Mexico Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Brazil Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Argentina Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Middle East and Africa Structural Heart Occlusion Devices Sales Market Share by Country (2021–2032)

Figure 52. Middle East and Africa Structural Heart Occlusion Devices Revenue Market Share by Country (2021–2032)

Figure 53. Turkey Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Saudi Arabia Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. UAE Structural Heart Occlusion Devices Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Global Sales Market Share of Structural Heart Occlusion Devices by Type (2021–2032)

Figure 57. Global Revenue Market Share of Structural Heart Occlusion Devices by Type (2021–2032)

Figure 58. Global Structural Heart Occlusion Devices Price (US$/Unit) by Type (2021–2032)

Figure 59. Global Sales Market Share of Structural Heart Occlusion Devices by Application (2021–2032)

Figure 60. Global Revenue Market Share of Structural Heart Occlusion Devices by Application (2021–2032)

Figure 61. Global Structural Heart Occlusion Devices Price (US$/Unit) by Application (2021–2032)

Figure 62. Structural Heart Occlusion Devices Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions